(2E)-1-(2,4-dimethoxyphenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

RGW-611, 5mg

Nitrofurazone, 98.0%, 1g

C-(1-Methyl-piperidin-4-yl)-methylamine, 95.0%, 25g

(2E)-3-(2-fluorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

4-(4-Chloropyrimidin-2-yl)morpholine, 95.0%, 1g

Trietilenglicol, mínimo 98%, para síntesis, 10 l, envase de plástico.

3-Ethyl-1-vinyl-1H-imidazol-3-ium Bromide>95.0%(HPLC)(T)5g

(R)-3-(Dodecanoyloxy)-2-hydroxypropyl (2-(trimethylammonio)ethyl) phosphate, 99%, 250mg

Methyl 5-bromo-4-nitrothiophene-2-carboxylate, 95.0%, 1g

4-Bromo-2,3,5,6-tetrafluorobenzaldehyde, 95.0%, 10g

3,5-Dibromo-N-(4-bromo-phenyl)-2-hydroxy-benzamide, 95.0%, 5g

6-CHLOROBENZO[D]ISOXAZOL-3-AMINE, 95.0%, 10g